TerryChinMDPh.D.
Allergy & Immunology • Long Beach, CAPediatric Asthma & Allergic Conditions
Physician
Dr. Chin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2801 Atlantic Ave
Long Beach, CA 90806Phone+1 562-933-8740Fax+1 562-933-8744
Summary
- Dr. Terry Chin is an allergist/immunologist in Long Beach, CA and is on the faculty of the University of California at Irvine at its multiple hospitals including Miller Children's & Women's Hospital Long Beach and Torrance Memorial Medical Center. After receiving his medical degree from Baylor College of Medicine and training at University of California, Irvine (residency) and Los Angeles (fellowship) he sees patients with allergic and immunologic conditions as well as children with pulmonary disorders such as asthma, bronchopulmonary dysplasia and was the associate director of the Cystic Fibrosis Clinic at Millers. He has more than 100 publications and served as reviewer for several journals.
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Pediatrics, 1983 - 1986
University of California (Irvine)/Children's Hospital of Orange CountyResidency, Pediatrics, 1980 - 1983
Baylor College of MedicineClass of 1977
Certifications & Licensure
CA State Medical License 1982 - 2025
TX State Medical License 1978 - 1984- American Board of Allergy and Immunology Allergy & Immunology
- American Board of Pediatrics Pediatrics
Awards, Honors, & Recognition
- Physician Excellence in Leadership MemorialCare, 2018
- Tribute to Champions of Hope 2014
- Applause Award Honoree Long Beach Memorial Health System, 2013
- Join now to see all
Clinical Trials
- Study of Ataluren in Nonsense Mutation Cystic Fibrosis (ACT CF) Start of enrollment: 2014 Aug 01
Publications & Presentations
PubMed
- 26 citationsLong-term safety and efficacy of tezacaftor–ivacaftor in individuals with cystic fibrosis aged 12 years or older who are homozygous or heterozygous for Phe508del CFTR ...Patrick A. Flume, Reta Fischer Biner, Damian G Downey, Cynthia A. Brown, Manu Jain
The Lancet. Respiratory Medicine. 2021-02-10 - 6 citationsWiskott-Aldrich Syndrome: Description of a New Gene Mutation With Normal Platelet Volume.Leila Yoonessi, Inderpal Randhawa, Eliezer Nussbaum, Samah Saharti, Paul C.M. Do
Journal of Pediatric Hematology/oncology. 2015-10-01 - 3 citationsReply: FEV1 Can Be Associated with Reduced Values after Vigorous Exercise in Healthy AdolescentsAlladdin Abosaida, Jen Jen Chen, Eliezer Nussbaum, Szu-Yun Leu, Terry Chin
Annals of the American Thoracic Society. 2015-07-23
Journal Articles
- Long-term safety and efficacy of tezacaftor-Carter in individuals with cystic fibrosis aged 12 years or olderFlume et al, Lancet Respiratory Medicine, 7/2021
Press Mentions
Cystic FibrosisMarch 28th, 2016
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
